Plexonal is widely used in the pharmaceutical industry as an intermediate in the synthesis of central nervous system (CNS) active compounds. It plays a key role in the production of certain sedatives and anxiolytic agents due to its ability to modulate neurotransmitter activity. Its structure allows for easy modification, making it valuable in developing new drug candidates with improved efficacy and reduced side effects. Additionally, Plexonal is employed in research settings for studying receptor binding and pharmacokinetic behavior of psychoactive substances. Its stability and reactivity profile support its use in scalable and reproducible chemical processes.